More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...
Dr Peter Marks is resigning as director of the FDA's Center for Biologics Evaluation and Research by April 5 due to objections to RFK Jr.
Against the backdrop of a rapidly expanding measles outbreak, what we need right now is urgent assistance from the federal ...
“What’s happening … is a reflection of the sprawling bureaucracy that’s actually making America sick and costing hundreds of ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
17hon MSN
The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...
Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...
Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.
18h
Bizcommunity on MSNSanofi-Novavax deal in jeopardy as FDA halts vaccine approvalDr Sara Brenner, the FDA's principal deputy commissioner, has paused the approval process for Novavax's Covid-19 vaccine by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results